Table 2.

Clinical data of four recipients with ischemic-type biliary lesion after ABO-incompatible adult living donor liver transplantation

Case No.	No. of pre-LT PE	Post-LT isoagglutinin peak titer (IgM/IgG)	No. of post-LT PE	Post-LT infection	Post-LT Liver Bx day	Pathology of liver Bx	LOS after LT (d)	ITBL free time (d)	Tx for ITBL	Tx period for ITBL (mo)	Outcome of ITBL tx	Patient's survival	Patient's survival time (mo)
2	1	1:4/1:8	0	No	27	ACR	35	90	PTBD	12	Graft failure	Dead	14
12	5	1:256/1:512	4	No	22	NSI	28	45	PTBD	5	Graft dysfunction, PVT	Alive	33
14	4	1:16/1:128	4	No	27	AMR	51	60	PTBD	11	Normal graft function	Alive	31
19	0	1:32/1:32	0	No	25	NSI	43	112	PTBD	20	Graft dysfunction	Alive	23

ITBL: Ischemic-type biliary lesion; ABO-I ALDLT: ABO-incompatible adult living donor liver transplantation; LT: Liver transplantation; PE: Plasma exchange; Bx: Biopsy; LOS: Length of hospital stay; Tx: Treatment; ACR: Acute cellular rejection; NSI: Non-specific inflammation; AMR: Antibody-mediated rejection; PTBD: Percutaneous transhepatic biliary drainage; PVT: Portal vein thrombosis.